Evidence map›Paper›PMID 30283093›Full record

ArticleScientific reports2018

Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia.

Ole Elvebakk, Christian Tronstad, Kåre I Birkeland, Trond G Jenssen, Marit R Bjørgaas, Kathrine F Frøslie, Kristin Godang, Håvard Kalvøy, Ørjan G Martinsen, Hanne L Gulseth

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Diabetes Technology Meeting 2020.Journal of diabetes science and technology · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ole ElvebakkDepartment of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway. ole.elvebakk@gmail.com.ORCID http://orcid.org/0000-0002-6779-1738
Christian TronstadDepartment of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.
Kåre I BirkelandDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Trond G JenssenDepartment of Organ Transplantation, Oslo University Hospital and University of Oslo, Oslo, Norway.
Marit R BjørgaasDepartment of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Kathrine F FrøslieNorwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway.
Kristin GodangDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Håvard KalvøyDepartment of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.
Ørjan G MartinsenDepartment of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.
Hanne L GulsethDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NONorwegian University of Science and Technology · NO

Funding

Ministry of Health and Care Services | Helse Sør-Øst RHF (Southern and Eastern Norway Regional Health Authority) 2013051
6 · The paper itself

Abstract

People with type 1 diabetes and impaired awareness of hypoglycaemia (IAH) are prone to severe hypoglycaemia. Previous attempts to develop non-invasive hypoglycaemia alarm systems have shown promising results, but it is not known if such alarms can detect severe hypoglycaemia in people with IAH. We aimed to explore whether a combination of non-invasive sensors could reliably evaluate hypoglycaemia (plasma glucose (PG) minimum 2.5 mmol/L) in people with IAH. Twenty participants with type 1 diabetes and IAH underwent randomly ordered, single blinded hyperinsulinemic euglycaemic and hyperinsulinemic hypoglycaemic clamps. Sweating, skin temperature, ECG, counterregulatory hormones and symptoms of hypoglycaemia were assessed. Overall, we were not able to detect clamp-induced hypoglycaemia with sufficient sensitivity and specificity for further clinical use. As a post-hoc analysis, we stratified participants according to their ability to identify hypoglycaemic symptoms during hypoglycaemic clamps. Five out of 20 participants could identify such symptoms. These participants had a significantly higher adrenaline response to hypoglycaemia (p < 0.001) and were reliably identified by sensors. Based on our observations, a non-invasive alarm system based on measurement of sweating responses and ECG changes during hypoglycaemia might provide an alert at a plasma glucose concentration around 2.5 mmol/L if an adequate sympatho-adrenal reaction is elicited.

Indexed as

Biosensing TechniquesBlood GlucoseAdultDiabetes Mellitus, Type 1EpinephrineFemaleGlucoseHumansHypoglycemiaHypoglycemic AgentsInsulinMaleSweatingBlood GlucoseEpinephrineGlucoseHypoglycemic AgentsInsulin

Identifiers

PMID30283093
PMCPMC6170450
OpenAlexW2893374845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.